Cellular Engineering Technologies

We are first-principles problem solvers, striving to continuously optimize workflows, improve safety profiles, and ultimately lower the cost of developing next-generation cell therapies. CET launches first characterized human somatic stem cell line products for research applications. CET manufactures first batch of human growth factor proteins from immortalized somatic stem cells. CET manufactures first batch of human growth factors from proprietary yeast lines. CET has entered into a manufacturing partnership with the University of Iowa’s Center for Biocatalysis and Bioprocessing to manufacture cGMP-grade human growth factors. Need a custom solution for a challenging cell manufacturing application? As bench scientists first and commercial solution providers second, we leverage decades of technical problem-solving in cellular and tissue engineering to develop best-in-class reprogramming methods and critical, high-value consumables for use in cell-based workflows. If safety, manufacturability and programming efficiency are priorities, discover how our patented upstream iPSC reprogramming methods set you up for downstream clinical success.